Adiposity and metabolic dysfunction in polycystic ovary syndrome

@article{Sam2015AdiposityAM,
  title={Adiposity and metabolic dysfunction in polycystic ovary syndrome},
  author={S. Sam},
  journal={Hormone Molecular Biology and Clinical Investigation},
  year={2015},
  volume={21},
  pages={107 - 116}
}
  • S. Sam
  • Published 2015
  • Biology, Medicine
  • Hormone Molecular Biology and Clinical Investigation
    • Abstract Polycystic ovary syndrome (PCOS) is the most common hormonal disorder among reproductive-age women and is associated with a high risk for metabolic disorders. Adiposity and insulin resistance are two prevalent conditions in PCOS and the likely culprits for the heightened metabolic risk. Up to 60% of women with PCOS are considered to be overweight or obese, and even among non-obese women with PCOS there is an increased accumulation of adipose tissue in abdominal depots. Insulin… CONTINUE READING
    View on PubMed
    doi.org
    20 Citations
    Highly Influential Citations
    1
    Background Citations
    10
    Results Citations
    1
    20 Citations
    Citation Type

    Citation Type

    Metabolic compromise in women with PCOS: earlier than expected.
    • PDF
    Treatment Strategies for the Infertile Polycystic Ovary Syndrome Patient
    • 11
    Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome
    Analysis of secreted peptidome from omental adipose tissue in polycystic ovarian syndrome patients
    • 5
    • Highly Influenced
    Serum Osteoprotegerin is Diminished in the Polycystic Ovary Syndrome and Associated with Insulin Resistance
    • Pérez de Ciriza
    • 2016
    • 3
    The impact of insulin resistance on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome
    • 10
    Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome
    • 12
    Evaluation of Carotid Artery Intima-Media Thickness as a Cardiovascular Risk Factor in Patients With Polycystic Ovary Syndrome
    MicroRNA-141 and MicroRNA-200c Are Overexpressed in Granulosa Cells of Polycystic Ovary Syndrome Patients
    • 4
    • PDF
    Quantification of visceral adipose tissue in polycystic ovary syndrome: dual-energy X-ray absorptiometry versus magnetic resonance imaging
    • 8

    References

    SHOWING 1-10 OF 154 REFERENCES
    Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
    • 89
    Role of obesity and adiposity in polycystic ovary syndrome
    • 94
    • PDF
    Mediators of chronic inflammation in polycystic ovarian syndrome
    • 51
    Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.
    • 557
    • PDF
    Adipocyte biology in polycystic ovary syndrome
    • 62
    Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.
    • 303
    • PDF
    Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.
    • 810
    • PDF
    Abdominal adiposity and the polycystic ovary syndrome
    • 274
    The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
    • 261
    • PDF
    Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.
    • 84
    • PDF